2025 · 2nd Quarter (Apr 1 - June 30)

INOZYME PHARMA

Filed by THE KPM GROUP DC LLC.

Open official filing

Source-reported fields

Filing overview

Type: Registration
Posted: Jul 15, 2025
Income: Not reported
Expenses: Not reported
Registrant: THE KPM GROUP DC LLC
Client: INOZYME PHARMA
Filing UUID: 9af3d134-0edb-463b-b301-f87428e91835
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act

Literal federal measure citations: H.R.1262, H.R.946, H.R. 1414, H.R.1532, H.R.1492

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.